Top Pharmaceutical Research Companies in South Korea
5 pharmaceutical research companies in South Korea, scored in 2026 on sample verification, fraud prevention and compliance, with the best use case for each.
Quick answer
For specialized patient journey and hard-to-reach expert insights, Global Vox Populi; for large-scale data and commercial analytics, IQVIA; for deep qualitative understanding of public healthcare sentiment, Ipsos; and for local field recruitment and regional survey execution, Gallup Korea.
Selecting from pharmaceutical research companies in South Korea requires careful assessment of whether a partner offers broad data access or granular, clinical-grade primary research. The market has matured, shifting from generic polling to highly specialized studies that demand deep knowledge of local prescriber behaviors, patient experiences, and regulatory compliance.
Decision-makers must balance the need for scale against the requirement for verified, high-quality data in an environment where access to physicians and patients is strictly regulated. This report assesses providers based on their ability to work through these complexities, making sure that your research investments yield actionable evidence that withstands scrutiny from both internal stakeholders and external observers.
Top Pharmaceutical Research Companies in South Korea: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Specialized clinical-grade patient journey research | 86.5 |
| 2 | IQVIA | Large-scale commercial data and real-world evidence | 83.0 |
| 3 | Ipsos | Global healthcare trends and patient perception research | 81.0 |
| 4 | M3 Global Research | Large-scale physician recruitment and quantitative fieldwork | 78.5 |
| 5 | Gallup Korea | Nationwide public and patient survey infrastructure | 73.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, patients, caregivers, payers, providers | Validation against license and registration records | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 28,366 healthcare professionals; 3,265 key opinion leaders; 1,150,843 patient profiles (in South Korea; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Pharma executives, pharmacy partners, wholesalers | Proprietary data systems | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos | Patients, citizens, healthcare stakeholders | Proprietary panel authentication | Not stated on pages reviewed | Not published | Not published | Not published |
| M3 Global Research | Physicians, healthcare professionals | Verified medical credentials | Not stated on pages reviewed | Not published | 2 million verified professionals worldwide (m3globalresearch.com, Oct 2026) | Not published |
| Gallup Korea | Patients, HCPs, general public | Proprietary field validation | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | ● | – | – | ● | – | – |
| Ipsos | ● | ● | ● | ● | – | ● |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Gallup Korea | ● | ● | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their specific capacity to deliver high-integrity pharmaceutical market research within the South Korean regulatory and healthcare environment.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures a provider's understanding of the South Korean healthcare system, including its specific reimbursement structures, prescriber habits, and regulatory constraints. High-scoring agencies demonstrate deep familiarity with local therapeutic areas and the nuances of how clinical practice differs from global standards, making sure research findings are contextually accurate and relevant. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO 9001, ISO 20252, and ISO/IEC 27001, alongside compliance with local data protection laws and health-specific regulations. For pharmaceutical research, it includes mandatory adverse event reporting protocols. A top-tier provider must demonstrate rigorous security measures to protect sensitive patient and physician data throughout the research lifecycle. |
| Target Audience Reach | 15 | This assesses the ability to access and profile specific respondent groups, including physicians, key opinion leaders, patients, and payers. Success depends on the size and quality of proprietary panels, the precision of profiling data points, and the ability to recruit for low-incidence conditions without relying on third-party aggregators. |
| Research Quality | 10 | This examines the rigor applied to questionnaire development, sampling methodology, and analytical frameworks. High-quality research requires solid validation of responses, effective detection of straight-lining or fraudulent completion, and a commitment to maintaining the integrity of the data collected from highly specialized and often time-poor medical professionals. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This covers the range of available research methods, from online surveys and CATI to qualitative techniques like in-depth interviews, ethnography, and focus groups. A capable agency offers a mix of quantitative scale and qualitative depth, providing the flexibility to select the most appropriate method for each specific research objective. |
| Analytical Capability | 5 | This measures the agency's skill in interpreting raw data to produce strategic recommendations. Beyond simple reporting, the provider should be able to identify patterns, segment audiences effectively, and connect research findings to the client's commercial objectives, ultimately supporting better-informed decision-making for brand managers and insights directors. |
| Client Service and Speed | 5 | This evaluates the responsiveness and project management efficiency of the agency. In a fast-moving pharmaceutical market, the ability to turn around projects, communicate clearly regarding milestones, and resolve fieldwork challenges promptly is essential for keeping product launches and market assessments on track. |
| Pricing and Feasibility Transparency | 5 | This assesses the honesty and clarity of the provider regarding project feasibility, incidence rates, and costs. A reliable agency provides realistic timelines and budget estimates early on, avoiding the common pitfalls of over-promising on recruitment or under-estimating the complexity of reaching specific medical audiences in South Korea. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in South Korea
Global Vox Populi: best for specialized clinical-grade patient journey research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitBest suited for brands requiring highly specific, verified insights in low-incidence therapeutic areas where data quality is essential.
Global Vox Populi serves as an independent partner for pharmaceutical firms requiring precision in their primary research. With a focus on healthcare market research in South Korea, the firm operates proprietary panels that are strictly managed for data integrity and participant validity.
The agency’s approach centers on deep profiling of healthcare professionals and patients across multiple therapeutic areas. By maintaining its own panels, the firm makes sure that recruitment for niche studies is grounded in reliable data, supporting the needs of brands working through the South Korean market.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in South Korea
28,366 panellists
- Primary & General9,868
- Internal Medicine Subspecialties3,260
- Surgical Specialties2,488
- Diagnostic & Laboratory2,176
- Acute, Peri-operative & Critical Care1,924
- Women's & Reproductive Health1,828
Key opinion leader panel, in South Korea
3,265 panellists
- Internal Medicine Subspecialties557
- Primary & General506
- Surgical Specialties347
- Diagnostic & Laboratory342
- Acute, Peri-operative & Critical Care263
- Nervous System & Mental Health217
Patient panel, in South Korea
1,150,843 patient profiles
- Aesthetics & Cosmetic369,820
- Cardiovascular88,046
- Ophthalmology67,475
- Endocrinology & Metabolic65,127
- Dermatology56,942
- Women's Health53,238
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in South Korea
1,075 panellists
- Provider: Access & Administrative Roles645
- Payer: Access & Coverage Roles430
Scorecard: 86.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 86.5 |
Core services
- HCP Research: Access to healthcare professionals and specialists for quantitative and qualitative studies.
- Patient Journey: In-depth research using the patient panel to map treatment experiences and disease management.
- KOL Engagement: Targeted outreach to key opinion leaders for expert consultation and strategic advisory.
- Payer Research: Studies involving payers and providers to understand access and coverage dynamics.
Strengths
- Verified Panel Assets: Maintains 28,366 HCPs and 1,150,843 patient profiles in South Korea, protecting high-quality, non-rented sample access.
- Clinical Compliance: Follows BHBIA guidance for adverse event reporting and maintains HIPAA-compliant handling of health data.
- Technical Rigor: Employs device fingerprinting, trap questions, and quality scoring to remove fraudulent completes before data delivery.
Innovation and technology
- Proprietary Platform: Surveys are hosted on an internal, purpose-built platform designed for high-security data collection and management.
- Mobile Engagement: Uses mobile and WhatsApp-assisted survey tools to reach time-poor medical professionals effectively.
Impact on businesses
- Strategic Decision Support: Provides clear data to inform brand positioning and market entry strategies for pharmaceutical assets.
- Risk Mitigation: Protects regulatory compliance and high-quality evidence, reducing the risk of flawed market intelligence.
Why it may fit your brief
The firm excels in projects demanding deep clinical expertise and strict adherence to research ethics. Firms seeking massive, automated commercial data sets may find larger, generalized consultancies more aligned with their specific infrastructure requirements.
IQVIA: best for large-scale commercial data and real-world evidence

Strongest fitIdeal for established pharmaceutical companies needing deep, data-heavy commercial analysis and clinical operational support.
IQVIA maintains a significant presence in South Korea, providing full-service research that connect data, technology, and analytics. The firm is known for its ability to handle large-scale projects, including real-world evidence generation and commercial performance monitoring.
For pharmaceutical clients, IQVIA offers a pathway to accelerate innovation through its data-driven platforms. Its services encompass clinical development support and end-to-end commercial execution, helping brands work through complex market dynamics with proprietary intelligence.
Scorecard: 83.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 83.0 |
Core services
- Market Intelligence: Provides commercial insights and predictive modeling to help firms monitor market performance and share of wallet.
- Clinical Development: Offers full-service clinical trial management and site identification using large-scale health data.
- Real-World Evidence: Generates data-backed evidence to assess treatment outcomes and patient adherence in clinical settings.
Strengths
- Data Depth: Access to massive proprietary databases and non-identified patient records to inform strategic decision-making.
- Technology Integration: Uses advanced AI-driven platforms to manage clinical trials and optimize field force effectiveness.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform designed to assist in clinical trial operations and commercial strategy.
Impact on businesses
- Asset Maximization: Helps clients optimize the probability of success for pharmaceutical assets in competitive environments.
Why it may fit your brief
The company is a strong choice for high-level strategic intelligence and large-scale data projects. Smaller, agility-focused research briefs may find more specialized primary research firms to be more responsive to individual study needs.
Ipsos: best for global healthcare trends and patient perception research

Strongest fitSuitable for companies looking to understand broad patient sentiment and public perception alongside market-specific trends.
Ipsos operates a well-established practice in South Korea, focusing on understanding the intersection of society, markets, and people. The firm provides specialized healthcare research that captures the voices of patients and the public.
By using data from surveys, social media, and qualitative methods, Ipsos assists clients in identifying market trends and brand health. Their work is characterized by a commitment to providing actionable truth for decision-makers in the healthcare sector.
Scorecard: 81.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.0 |
Core services
- Brand Health Tracking: Monitors brand performance and perception among healthcare stakeholders over time.
- Patient Experience: Studies focusing on patient perceptions of care quality and healthcare system satisfaction.
- Market Understanding: Delivers insights into market trends and public health concerns through global and local research.
Strengths
- Global Reach: Uses international trends data to provide context for local research findings in South Korea.
- Methodological Variety: Offers a broad array of research tools, including online communities and specialized qualitative panels.
Innovation and technology
- AI Insights: Uses AI to analyze vast amounts of data and deliver insights more consistently.
Impact on businesses
- Strategic Guidance: Helps clients act faster and smarter by turning survey data into actionable market understanding.
Why it may fit your brief
Ipsos is well-equipped for studies that require a blend of public opinion data and specific patient feedback. Firms focused solely on clinical-grade prescriber data might prefer agencies with a narrower focus on medical professional panels.
M3 Global Research: best for large-scale physician recruitment and quantitative fieldwork

Strongest fitWell-suited for clients requiring quick access to large numbers of verified physicians for quantitative surveys.
M3 Global Research maintains a local team in South Korea, using its global panel of verified physicians and healthcare professionals. The firm is recognized for its ability to support market research with high-volume recruitment and fieldwork services.
By connecting medical experts with research opportunities, the firm provides pharmaceutical and life science clients with access to valuable real-world perspectives. Their services are designed to assist with both quantitative and qualitative research requirements in the healthcare domain.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Fieldwork Services: Provides full-service data collection and recruitment for pharmaceutical market research.
- Panel Recruitment: Connects researchers with a global network of verified physicians and healthcare professionals.
- Support Services: Assists with the end-to-end management of market research projects, from design to data delivery.
Strengths
- Physician Access: Maintains a large, verified panel of medical professionals, supporting rapid recruitment.
- Global Coverage: Supports research across numerous markets, protecting consistent methodology in global projects.
Innovation and technology
- Digital Panel Tools: Offers online tools for physicians to manage their participation and research opportunities.
Impact on businesses
- Actionable Insight Access: Enables firms to reach influential physicians quickly to inform product and strategy development.
Why it may fit your brief
The agency is optimized for high-volume recruitment of medical professionals. For studies requiring highly localized, bespoke qualitative work with niche patient groups, firms might look to agencies with more dedicated qualitative staff.
Gallup Korea: best for nationwide public and patient survey infrastructure

Strongest fitIdeal for projects requiring extensive, nationwide reach and reliable field execution within South Korea.
Gallup Korea is a long-standing research agency with an extensive field network across the country. Their capabilities include specialized studies for the pharmaceutical sector, drawing on deep local knowledge and established survey infrastructure.
The agency provides actionable insights by combining traditional CATI and CAPI methods with proprietary access panels. Their focus is on delivering reliable data that reflects the realities of the South Korean public and healthcare environment.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | gallup.co.kr (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Nationwide Surveys: Conducts large-scale surveys using CATI and CAPI facilities throughout South Korea.
- Healthcare Research: Provides specialized studies targeting HCPs and patients for pharmaceutical clients.
- Data Collection: Maintains a solid field network for reliable, high-quality data gathering across all regions.
Strengths
- Local Authority: Possesses deep understanding of the local South Korean market and cultural nuances.
- Solid Infrastructure: Maintains extensive nationwide survey facilities and a well-trained field force.
Innovation and technology
- Survey Technology: Uses modern survey platforms to manage data collection and protect respondent accuracy.
Impact on businesses
- Strategic Intelligence: Supports both public and private sector clients with reliable data for informed decision-making.
Why it may fit your brief
Gallup Korea is a strong partner for projects requiring deep local roots and large-scale survey reach. For highly specialized, internationalized pharmaceutical research, global agencies may offer more integrated cross-border methodologies.
How HCP and patient verification actually works in South Korea
Verify the authenticity of healthcare professionals and patients through rigorous, multi-layered credentialing and ongoing validation checks.
Credential Validation Procedures
Any reputable research partner must validate healthcare professionals against official medical registries and license databases. For patients, verification should involve secondary source matching or health-related screening questions. Ask for proof of their validation workflow, including how often they refresh these records. If a provider cannot explain how they confirm a physician's specialty or a patient's diagnosis, the data quality is likely compromised.
Digital Identity Checks
Providers should use device and identity fingerprinting to make sure that one person is not completing the same survey multiple times. This includes geo-location checks to block VPN usage. Ask how they identify and purge bots from their panels. A lack of transparent digital security protocols is a primary red flag for unreliable quantitative data.
Behavioral Quality Monitoring
Look for firms that use trap questions and speeding detection to identify respondents who are not paying attention. High-quality agencies will remove these completions before the final data set is delivered. Ask for their specific completion-quality scoring metrics. If they cannot provide data on their removal rates, you may be paying for low-effort responses.
Ongoing Panel Refresh
Professional panels must be actively managed. Ask how the provider recruits new members and how they handle inactive participants. A stagnant panel is prone to professional survey-takers who provide biased feedback. A strong provider will show a clear strategy for re-validating members on a rolling basis to make sure the audience remains representative of current clinical or patient realities.
How to choose the right provider in South Korea
Select a partner based on their alignment with your specific research methodology and the depth of their local healthcare access.
- Define Research Needs: Determine if you need broad market trends or deep, clinical-grade patient journey insights. This distinction dictates whether you prioritize large-scale data providers or specialized primary research firms.
- Assess Local Expertise: Check that the provider understands the South Korean healthcare environment, including local regulations and prescriber behavior. A partner with a physical team in Seoul often handles local nuances more effectively.
- Verify Panel Quality: Ask if the panel is proprietary or rented. Proprietary panels generally offer better control over quality and recruitment, which is essential for specialized medical research.
- Review Compliance Standards: Make sure the agency meets ISO certifications and understands local data protection laws. This is non-negotiable for handling sensitive health data and managing adverse event reporting.
- Evaluate Feasibility First: Require a pre-study feasibility check for your target audience. Avoid providers who promise access without clear evidence of their panel size and historical recruitment data.
Questions to ask before you commission
- Can you describe your specific validation process for verifying the medical credentials of your South Korean physician panel?
- How does your firm handle adverse event reporting in compliance with local and international pharmaceutical research guidelines?
- What specific measures do you take to identify and remove fraudulent or bot-generated responses in your quantitative studies?
- Can you provide a feasibility assessment for my specific target audience before we commit to the project?
- How do you make sure that your panel members are representative of the diverse patient demographics in South Korea?
- What is your approach to qualitative recruitment for hard-to-reach subspecialties in the local market?
Common pitfalls to avoid
- Relying on Rented Panels: Using rented lists often leads to poor data quality and duplicate respondents who are not truly representative of the medical community.
- Ignoring Compliance Protocols: Failing to verify a provider's adverse event reporting procedures can result in significant legal and regulatory risks for your brand.
- Overlooking Local Nuance: Treating the South Korean market as identical to other regions often results in flawed survey design and irrelevant insights for local prescribers.
- Assuming Feasibility: Committing to a project without a documented feasibility report often leads to missed deadlines when recruitment targets for niche patients are not met.
What a feasibility check should include
Mandate a documented feasibility report that includes granular panel counts for your specific target audience before any project begins.
Detailed Audience Breakdown
A feasibility check must specify the number of available, active participants matching your exact criteria. This makes sure the research is viable before you invest time and resources.
Recruitment Methodology
Understand how the provider will source participants if the panel is not sufficiently large. Knowing the source makes sure you can trust the quality of the recruits.
Incidence Rate Estimation
The provider should provide a realistic estimate of how many people they need to contact to reach your required sample size. This prevents unrealistic timelines.
Historical Performance Data
Ask to see how the agency has performed in similar studies previously. Past success is the best predictor of their ability to deliver on your project.
Conclusion
Choosing the right partner from the available pharmaceutical research companies in South Korea involves matching your specific business objectives with the distinct strengths of the providers. For large-scale data and commercial analytics, global firms like IQVIA provide the necessary infrastructure and predictive intelligence. If your goal is deep qualitative understanding or specialized patient journey research, independent experts like Global Vox Populi offer the clinical-grade panels and rigorous compliance required to protect data integrity.
Use the scorecard provided to weight your specific needs against each agency’s core capabilities. Focus on the ability to verify participants and maintain ethical standards, as these factors are the bedrock of reliable pharmaceutical research. By prioritizing transparent feasibility and high-quality audience access, you will make sure that your research investments translate into meaningful strategic advantages in the South Korean market.
Planning research in South Korea? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Who are the top pharmaceutical market research companies in South Korea?
The market includes global leaders like IQVIA and Ipsos, as well as specialized players like Global Vox Populi and Gallup Korea. The 'best' choice depends on your specific needs: IQVIA for massive data sets, Global Vox Populi for verified clinical and patient panels, and Gallup Korea for broad nationwide polling.
How do I conduct pharmaceutical market research in South Korea?
Conducting research requires a clear understanding of local regulations, including strict data privacy and adverse event reporting requirements. You must partner with an agency that maintains verified panels of physicians and patients and follows international codes such as the ICC/ESOMAR Code to make sure your research is both ethical and actionable.
Are there local healthcare market research agencies in Seoul?
Yes, several agencies maintain dedicated offices and local teams in Seoul. Firms such as Global Vox Populi, IQVIA, Ipsos, and Gallup Korea all have local operations that provide the necessary presence to manage fieldwork and work through the South Korean healthcare system effectively.
What is the best way to reach Korean physicians for market research?
The most reliable way is through proprietary panels that are recruited via professional associations and verified medical registries. These panels make sure that participants are actual, practicing physicians. Avoid using generic online panels, which often fail to provide the necessary verification for high-quality medical research.
Does IQVIA have a presence in South Korea?
Yes, IQVIA maintains a significant office and local team in South Korea. They provide a range of services including commercial insights, real-world evidence generation, and clinical trial support, making them a key player for pharmaceutical companies looking for data-driven strategic intelligence.
How does the South Korean healthcare system affect pharmaceutical market research?
The South Korean healthcare system is heavily regulated, with specific reimbursement structures and a centralized approach to patient data. Research must comply with local data protection laws and specific adverse event reporting protocols. Understanding these nuances is essential for any agency operating in the market.
Are there specialized agencies for patient journey research in South Korea?
Yes, several agencies, including Global Vox Populi and Ipsos, offer specialized patient journey research. These firms use proprietary patient panels and qualitative methods to map the experience of patients across various therapeutic areas, providing the depth needed for brand-specific market access and engagement strategies.
What are the key differences between these research companies?
The primary differences lie in their focus. Some, like IQVIA, are data-heavy and commercial-focused. Others, like Global Vox Populi, specialize in primary, clinical-grade primary research with verified panels. Gallup Korea offers strong local field infrastructure, while Ipsos excels in global trend analysis and public sentiment.